Keebeck Alpha »

Karuna Therapeutics Ord shares owned by Keebeck Alpha

Quarter-by-quarter ownership of Karuna Therapeutics Ord shares owned by Keebeck Alpha from 13F filings

Historical chart of Keebeck Alpha investment in Karuna Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Karuna Therapeutics Ord held by Keebeck Alpha consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Karuna Therapeutics Ord by Keebeck Alpha

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.0M 6.3k 316.51

More positions owned by Keebeck Alpha

American Equity Investment Life Holding (AEL)
stock
Sp Plus (SP)
Cerevel Therapeutics Hldng I (CERE)
Karuna Therapeutics Ord
Amedisys (AMED)
ImmunoGen
Hess (HES)
Sovos Brands
Pioneer Natural Resources (PXD)
Capstar Finl Hldgs (CSTR)
Neogames S A SHS (NGMS)
Capri Holdings SHS (CPRI)
Ishares Tr Russell 2000 Etf (IWM)
Consolidated Communications Holdings (CNSL)

View all positions for Keebeck Alpha

Top funds holding Karuna Therapeutics Ord

Vanguard Group
T. Rowe Price Associates
Pentwater Capital Management
Wellington Management Company
UBS Group
Alliancebernstein
Norges Bank Investment Management
Balyasny Asset Management
First Light Asset Management
Citadel Advisors
Boxer Capital
Charles Schwab Investment Management
Alpine Associates Management
Avidity Partners Management
Goldman Sachs Group

View all funds holding Karuna Therapeutics Ord